193 related articles for article (PubMed ID: 23269623)
1. Circulation insulin-like growth factor peptides and colorectal cancer risk: an updated systematic review and meta-analysis.
Chi F; Wu R; Zeng YC; Xing R; Liu Y
Mol Biol Rep; 2013 May; 40(5):3583-90. PubMed ID: 23269623
[TBL] [Abstract][Full Text] [Related]
2. Circulating insulin-like growth factor peptides and prostate cancer risk: a systematic review and meta-analysis.
Rowlands MA; Gunnell D; Harris R; Vatten LJ; Holly JM; Martin RM
Int J Cancer; 2009 May; 124(10):2416-29. PubMed ID: 19142965
[TBL] [Abstract][Full Text] [Related]
3. Circulating levels of IGF-1, IGFBP-3, and IGF-1/IGFBP-3 molar ratio and colorectal adenomas: A meta-analysis.
Yoon YS; Keum N; Zhang X; Cho E; Giovannucci EL
Cancer Epidemiol; 2015 Dec; 39(6):1026-35. PubMed ID: 26388613
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like Growth Factor-1, IGF-binding Protein-3, C-peptide and Colorectal Cancer: a Case-control Study.
Pankaj J; Kumari JR; Kim W; Lee SA
Asian Pac J Cancer Prev; 2015; 16(9):3735-40. PubMed ID: 25987030
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor-I and insulin are associated with the presence and advancement of adenomatous polyps.
Schoen RE; Weissfeld JL; Kuller LH; Thaete FL; Evans RW; Hayes RB; Rosen CJ
Gastroenterology; 2005 Aug; 129(2):464-75. PubMed ID: 16083703
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor (IGF)-I, IGF-II, IGF binding protein-3, and risk of colorectal cancer: a nested case-control study in the Japan Collaborative Cohort study.
Suzuki S; Kojima M; Tokudome S; Suzuki K; Ozasa K; Ito Y; Inaba Y; Tajima K; Nakachi K; Watanabe Y; Tamakoshi A;
Asian Pac J Cancer Prev; 2009 Dec; 10 Suppl():45-9. PubMed ID: 20553081
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factors and cancer: no role in screening. Evidence from the BUPA study and meta-analysis of prospective epidemiological studies.
Morris JK; George LM; Wu T; Wald NJ
Br J Cancer; 2006 Jul; 95(1):112-7. PubMed ID: 16804529
[TBL] [Abstract][Full Text] [Related]
8. [Study on the relations between serum insulin-like growth factor-1, insulin-like growth factor binding protein-3 and colorectal cancer: a meta-analysis].
Duan QH; Wang ZG; Zhu GB; Lu ZX; Shi LY; Nie SF
Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Feb; 26(2):132-4. PubMed ID: 15921617
[TBL] [Abstract][Full Text] [Related]
9. Detection and identification of oxidized insulin-like growth factor-binding proteins and receptors in patients with colorectal carcinoma.
Nedić O; Robajac D; Šunderić M; Miljuš G; Đukanović B; Malenković V
Free Radic Biol Med; 2013 Dec; 65():1195-1200. PubMed ID: 24051179
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of IGF-I, IGFBP-3 and colorectal cancer risk: results from the EPIC cohort, plus a meta-analysis of prospective studies.
Rinaldi S; Cleveland R; Norat T; Biessy C; Rohrmann S; Linseisen J; Boeing H; Pischon T; Panico S; Agnoli C; Palli D; Tumino R; Vineis P; Peeters PH; van Gils CH; Bueno-de-Mesquita BH; Vrieling A; Allen NE; Roddam A; Bingham S; Khaw KT; Manjer J; Borgquist S; Dumeaux V; Torhild Gram I; Lund E; Trichopoulou A; Makrygiannis G; Benetou V; Molina E; Donate Suárez I; Barricarte Gurrea A; Gonzalez CA; Tormo MJ; Altzibar JM; Olsen A; Tjonneland A; Grønbaek H; Overvad K; Clavel-Chapelon F; Boutron-Ruault MC; Morois S; Slimani N; Boffetta P; Jenab M; Riboli E; Kaaks R
Int J Cancer; 2010 Apr; 126(7):1702-15. PubMed ID: 19810099
[TBL] [Abstract][Full Text] [Related]
11. Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women.
Kaaks R; Toniolo P; Akhmedkhanov A; Lukanova A; Biessy C; Dechaud H; Rinaldi S; Zeleniuch-Jacquotte A; Shore RE; Riboli E
J Natl Cancer Inst; 2000 Oct; 92(19):1592-600. PubMed ID: 11018095
[TBL] [Abstract][Full Text] [Related]
12. Genetic variants, prediagnostic circulating levels of insulin-like growth factors, insulin, and glucose and the risk of colorectal cancer: the Multiethnic Cohort study.
Ollberding NJ; Cheng I; Wilkens LR; Henderson BE; Pollak MN; Kolonel LN; Le Marchand L
Cancer Epidemiol Biomarkers Prev; 2012 May; 21(5):810-20. PubMed ID: 22354904
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis.
Renehan AG; Zwahlen M; Minder C; O'Dwyer ST; Shalet SM; Egger M
Lancet; 2004 Apr; 363(9418):1346-53. PubMed ID: 15110491
[TBL] [Abstract][Full Text] [Related]
14. Serum Insulin-Like Growth Factor Axis and the Risk of Pancreatic Cancer: Systematic Review and Meta-Analysis.
Gong Y; Zhang B; Liao Y; Tang Y; Mai C; Chen T; Tang H
Nutrients; 2017 Apr; 9(4):. PubMed ID: 28420208
[TBL] [Abstract][Full Text] [Related]
15. Association of circulating insulin-like growth factor 1 and insulin-like growth factor binding protein 3 with the risk of ovarian cancer: A systematic review and meta-analysis.
Wang Q; Bian CE; Peng H; He L; Zhao X
Mol Clin Oncol; 2015 May; 3(3):623-628. PubMed ID: 26137278
[TBL] [Abstract][Full Text] [Related]
16. Assessing the potential usefulness of IGF-related peptides and adiponectin for predicting disease risk.
Belobrajdic DP; Priebe IK; Forbes B; Flyvbjerg A; Chen JW; Cosgrove LJ; Frystyk J; Saunders IW
Growth Horm IGF Res; 2008 Jun; 18(3):198-204. PubMed ID: 17928251
[TBL] [Abstract][Full Text] [Related]
17. A prospective study of C-peptide, insulin-like growth factor-I, insulin-like growth factor binding protein-1, and the risk of colorectal cancer in women.
Wei EK; Ma J; Pollak MN; Rifai N; Fuchs CS; Hankinson SE; Giovannucci E
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):850-5. PubMed ID: 15824155
[TBL] [Abstract][Full Text] [Related]
18. Insulin, the insulin-like growth factor axis, and mortality in patients with nonmetastatic colorectal cancer.
Wolpin BM; Meyerhardt JA; Chan AT; Ng K; Chan JA; Wu K; Pollak MN; Giovannucci EL; Fuchs CS
J Clin Oncol; 2009 Jan; 27(2):176-85. PubMed ID: 19064975
[TBL] [Abstract][Full Text] [Related]
19. Insulin resistance, apoptosis, and colorectal adenoma risk.
Keku TO; Lund PK; Galanko J; Simmons JG; Woosley JT; Sandler RS
Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2076-81. PubMed ID: 16172212
[TBL] [Abstract][Full Text] [Related]
20. The insulin-like growth factor axis: A biological mechanism linking physical activity to colorectal cancer survival.
Sax AT; Jenkins DG; Devin JL; Hughes GI; Bolam KA; Skinner TL
Cancer Epidemiol; 2014 Aug; 38(4):455-9. PubMed ID: 24968815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
